Skip to main content

Table 5 Subgroup analyses comparing IJV versus SCVa

From: Internal jugular vein versus subclavian vein as the percutaneous insertion site for totally implantable venous access devices: a meta-analysis of comparative studies

Group TIVAD-related infections Catheter-related thrombotic complications Total major mechanical complications
N OR (95 % CI) I2(%) P heterogeneity N OR (95 % CI) I2(%) P heterogeneity N OR (95 % CI) I2(%) P heterogeneity
Overall 11 0.71 (0.48–1.04) 0.0 0.963 11 0.76 (0.38–1.51) 30.2 0.159 11 0.38 (0.24–0.61) 31.6 0.147
Use of antibiotic prophylaxis
Yes 3 0.69 (0.27–1.76) 0.0 0.611 NA NA NA NA NA NA NA NA
No 2 0.69 (0.39–1.24) 0.0 0.618 NA NA NA NA NA NA NA NA
Use of ultrasound guidance
Yes 1 0.40 (0.02–6.41) NA NA 1 1.00 (0.19–5.23) NA NA 1 0.39 (0.08–1.98) NA NA
No 6 0.76 (0.47–1.24) 0.0 0.798 5 0.44 (0.18–1.05) 0.0 0.860 6 0.38 (0.18–0.79) 46.3 0.098
Age Group
< 18 yr 1 0.50 (0.14–1.80) NA NA 1 0.41 (0.02–10.40) NA NA 1 0.27 (0.10–0.76) NA NA
≥ 18 yr 3 0.44 (0.16–1.22) 0.0 0.972 4 1.13 (0.28–4.61) 56.8 0.073 3 0.61 (0.15–2.56) 56.5 0.100
  1. Abbreviations: N Number of studies, NA not applicable, yr years old
  2. aAll these analyses were performed with random-effects model